Daniel Brook

Daniel Brook's research focuses on improving access to treatment for opioid use disorder and hepatitis C virus (HCV) infection among people who use drugs in rural communities in the United States. His work examines how policies (like Medicaid coverage), primary care practices, and testing programs affect the ability of rural patients to get buprenorphine (a medication for opioid addiction) and HCV treatment, often using genomic tracking of virus transmission and large multi-site study data. Much of the recent work is part of the multi-site Rural Opioid Initiative, combining epidemiology, health policy, and implementation science methods.

Publication output has grown substantially over the last decade, rising from occasional single papers before 2020 to a peak of 9 publications in 2024, indicating increasing recent activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026